These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 2411397)

  • 41. The quantitative determination of metabolites of 6-mercaptopurine in biological materials. VII. Chemical synthesis by phosphorylation of 6-thioguanosine 5'-monophosphate, 5'-diphosphate and 5'-triphosphate, and their purification and identification by reversed-phase/ion-pair high-performance liquid chromatography and by various enzymatic assays.
    Breter HJ; Mertes H
    Biochim Biophys Acta; 1990 Feb; 1033(2):124-32. PubMed ID: 2306458
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A clinically useful ion-pairing high-performance liquid chromatographic assay for the monophosphate metabolites of thioguanine and mercaptopurine in human neoplastic cells.
    Zimm S; Strong JM
    Anal Biochem; 1987 Jan; 160(1):1-6. PubMed ID: 3471095
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Three Faces of Mercaptopurine Cytotoxicity In Vitro: Methylation, Nucleotide Homeostasis, and Deoxythioguanosine in DNA.
    Coulthard SA; McGarrity S; Sahota K; Berry P; Redfern CPF
    Drug Metab Dispos; 2018 Aug; 46(8):1191-1199. PubMed ID: 29884651
    [TBL] [Abstract][Full Text] [Related]  

  • 44. 6-mercaptopurine promotes energetic failure in proliferating T cells.
    Fernández-Ramos AA; Marchetti-Laurent C; Poindessous V; Antonio S; Laurent-Puig P; Bortoli S; Loriot MA; Pallet N
    Oncotarget; 2017 Jun; 8(26):43048-43060. PubMed ID: 28574837
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Phosphorylation of 6-mercaptopurine in human leukemic cells and phosphoribosylpyrophosphate.
    Higuchi T
    Nihon Ketsueki Gakkai Zasshi; 1975 Jun; 38(3):248-58. PubMed ID: 1243219
    [No Abstract]   [Full Text] [Related]  

  • 46. On the Cellular Pharmacokinetics of 6-Thioguanine in Acute Myelogenous Leukemia.
    Liliemark J; Pettersson B; Järnmark M; Peterson C
    Leuk Lymphoma; 1991; 4(4):271-6. PubMed ID: 27463047
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The quantitative determination of metabolites of 6-mercaptopurine in biological materials. VI. Evidence for posttranscriptional modification of 6-thioguanosine residues in RNA from L5178Y cells treated with 6-mercaptopurine.
    Breter HJ
    Biochim Biophys Acta; 1985 May; 825(1):39-44. PubMed ID: 4039607
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mechanistic mathematical modelling of mercaptopurine effects on cell cycle of human acute lymphoblastic leukaemia cells.
    Panetta JC; Evans WE; Cheok MH
    Br J Cancer; 2006 Jan; 94(1):93-100. PubMed ID: 16333308
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A rapid and sensitive high-performance liquid chromatographic assay for 6-mercaptopurine metabolites in red blood cells.
    Lavi LE; Holcenberg JS
    Anal Biochem; 1985 Feb; 144(2):514-21. PubMed ID: 4039541
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The quantitative determination of metabolites of 6-mercaptopurine in biological materials. III. The determination of 14C-labeled 6-thiopurines in L5178Y cell extracts using high-pressure liquid cation-exchange chromatography.
    Breter HJ; Maidhof A; Zahn RK
    Biochim Biophys Acta; 1978 Apr; 518(2):205-15. PubMed ID: 418811
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Metabolism of 6-Mercaptopurine by Resistant Escherichia coli Cells.
    Coggin JH; Loosemore M; Martin WR
    J Bacteriol; 1966 Aug; 92(2):446-54. PubMed ID: 16562134
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Phosphorylation of 6-mercaptopurine in human leukemic cells.
    Higuchi T
    Nihon Ketsueki Gakkai Zasshi; 1974 Jun; 37(3):282-8. PubMed ID: 4479918
    [No Abstract]   [Full Text] [Related]  

  • 53. Functional comparison of human and murine equilibrative nucleobase transporter 1.
    Kim CS; Sayler AL; Dean H; Ruel NM; Hammond JR
    PLoS One; 2024; 19(10):e0311519. PubMed ID: 39361655
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cdc45 limits replicon usage from a low density of preRCs in mammalian cells.
    Wong PG; Winter SL; Zaika E; Cao TV; Oguz U; Koomen JM; Hamlin JL; Alexandrow MG
    PLoS One; 2011 Mar; 6(3):e17533. PubMed ID: 21390258
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Molecular pharmacodynamics in childhood leukemia.
    Pieters R; den Boer ML
    Int J Hematol; 2003 Dec; 78(5):402-13. PubMed ID: 14704032
    [No Abstract]   [Full Text] [Related]  

  • 56. Variability of 6-mercaptopurine pharmacokinetics during oral maintenance therapy of children with acute leukemia.
    Lafolie P; Björk O; Hayder S; Ahström L; Peterson C
    Med Oncol Tumor Pharmacother; 1989; 6(4):259-65. PubMed ID: 2615529
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cellular pharmacokinetics of mercaptopurine in human neoplastic cells and cell lines.
    Zimm S; Johnson GE; Chabner BA; Poplack DG
    Cancer Res; 1985 Sep; 45(9):4156-61. PubMed ID: 2411397
    [TBL] [Abstract][Full Text] [Related]  

  • 58. On the paradoxically concentration-dependent metabolism of 6-mercaptopurine in WEHI-3b murine leukemia cells.
    Liliemark J; Pettersson B; Engberg B; Lafolie P; Masquelier M; Peterson C
    Cancer Res; 1990 Jan; 50(1):108-12. PubMed ID: 2293545
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Methylation of mercaptopurine, thioguanine, and their nucleotide metabolites by heterologously expressed human thiopurine S-methyltransferase.
    Krynetski EY; Krynetskaia NF; Yanishevski Y; Evans WE
    Mol Pharmacol; 1995 Jun; 47(6):1141-7. PubMed ID: 7603453
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Biochemical parameters of mercaptopurine activity in patients with acute lymphoblastic leukemia.
    Zimm S; Reaman G; Murphy RF; Poplack DG
    Cancer Res; 1986 Mar; 46(3):1495-8. PubMed ID: 2417705
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.